RAPID ONSET OF CHRONIC GRANULOCYTIC-LEUKEMIA AFTER TREATMENT FOR HODGKINS-DISEASE

被引:12
作者
JACKSON, GH
LATHAM, JA
LENNARD, AL
TAYLOR, PRA
PROCTOR, SJ
机构
[1] Department of Haematology, Royal Victoria Infirmary, Newcastle upon Tyne NE1 4LP, Queen Victoria Road
关键词
HODGKINS DISEASE; ABMT; CGL; SECONDARY LEUKEMIA;
D O I
10.1111/j.1365-2141.1994.tb04891.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
A 17-year-old white female presented with stage IVB Hodgkin's disease. After chemotherapy and radiotherapy she achieved a complete clinical remission and underwent an autologous bone marrow transplant (ABMT). 22 months later she developed chronic granulocytic leukaemia (CGL). Polymerase chain reaction (PCR) analysis of bone marrow harvested at the time of ABMT did not show any evidence of the bcr-abl sequence that was detectable at the diagnosis of CGL. This case provides further information on the kinetics of the development of CGL and adds to the small pool of data on CGL developing after treatment for Hodgkin's disease.
引用
收藏
页码:193 / 195
页数:3
相关论文
共 15 条
[1]  
BERMAN E, 1991, BLOOD, V78, P2969
[2]  
BOUABOALLAH K, 1991, CANCER GENET CYTOGEN, V55, P227
[3]  
CANELLOS GP, 1972, LANCET, V1, P1227
[4]   ISOLATION OF BIOLOGICALLY-ACTIVE RIBONUCLEIC-ACID FROM SOURCES ENRICHED IN RIBONUCLEASE [J].
CHIRGWIN, JM ;
PRZYBYLA, AE ;
MACDONALD, RJ ;
RUTTER, WJ .
BIOCHEMISTRY, 1979, 18 (24) :5294-5299
[5]  
COLTMAN CA, 1982, CANCER TREAT REP, V66, P1023
[6]   MINIMAL RESIDUAL DISEASE AFTER BONE-MARROW TRANSPLANT FOR CHRONIC MYELOID-LEUKEMIA DETECTED BY THE POLYMERASE CHAIN-REACTION [J].
CROSS, NCP ;
LIN, F ;
BUNGEY, J ;
GOLDMAN, JM .
LEUKEMIA & LYMPHOMA, 1993, 11 :39-43
[7]   EPIPODOPHYLLOTOXINS, ALKYLATING-AGENTS, AND RADIATION AND RISK OF SECONDARY LEUKEMIA AFTER CHILDHOOD-CANCER [J].
HAWKINS, MM ;
WILSON, LMK ;
STOVALL, MA ;
MARSDEN, HB ;
POTOK, MHN ;
KINGSTON, JE ;
CHESSELLS, JM .
BRITISH MEDICAL JOURNAL, 1992, 304 (6832) :951-958
[8]  
MOLONEY WC, 1987, BLOOD, V70, P905
[9]  
OFFIT K, 1990, BLOOD, V75, P1346
[10]  
PROCTOR SJ, 1991, EUR J CANCER, V27, P624, DOI 10.1016/0277-5379(91)90231-2